1. Current Challenges for Fasciolicide Treatment in Ruminant Livestock
- Author
-
Victoria Martínez-Sernández, José Antonio Castro-Hermida, Mercedes Mezo, Florencio M. Ubeira, and Marta González-Warleta
- Subjects
0301 basic medicine ,Fascioliasis ,Livestock ,030231 tropical medicine ,Drug Resistance ,Pharmacological treatment ,Ruminant livestock ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,parasitic diseases ,medicine ,Animals ,media_common.cataloged_instance ,Veterinary drug ,Fasciolosis ,Animal Husbandry ,European union ,media_common ,Anthelmintics ,Fasciola ,biology ,business.industry ,Ruminants ,medicine.disease ,biology.organism_classification ,030104 developmental biology ,Infectious Diseases ,Parasitology ,Business - Abstract
Pharmacological treatment remains essential to control fasciolosis in areas where infection is endemic. However, there are major constraints to treating food-producing animals. Of particular concern is the lack of flukicides for treating early Fasciola infections in ruminant livestock in some countries. In addition, the information provided in package leaflets, particularly regarding withdrawal periods, is often incomplete, confusing, and/or contradictory. International regulatory bodies should harmonize the use of flukicides in livestock in favor of fairer, safer international trade. In addition, monitoring the efficacy of fasciolicides on farms is also essential to minimize the spread of drug-resistant populations of Fasciola. The current situation regarding flukicide formulations in the European Union and other, non-European countries is analyzed in this review paper.
- Published
- 2021
- Full Text
- View/download PDF